Ethical priorities for international collaborative adaptive platform trials for public health emergencies

• Paul Glasziou,
• Joseph Ali,
• Nina Gobat,
• Katharine Wright,
• Tanja Kuchenmüller,
• Alun Davies,
• Andreas Reis,
• Jerome Amir Singh,
• Katherine Littler,
• Chelsea Modlin,
• Lee-Anne Pascoe

Affiliations

Paul Glasziou

4 Institute for Evidence-Based Healthcare, Bond University, Robina, Queensland, Australia

Joseph Ali

2 Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland, USA

Nina Gobat

5 Community Readiness and Resilience Unit, World Health Organization, Geneva, Switzerland

Katharine Wright

1 Consultant, World Health Organization, Geneva, Switzerland

Tanja Kuchenmüller

6 Evidence to Policy and Impact Unit, World Health Organization, Geneva, Switzerland

Alun Davies

3 Nuffield Department of Medicine, University of Oxford, Oxford, UK

Andreas Reis

7 Health Ethics and Governance Unit, WHO, Geneva, GE, Switzerland

Jerome Amir Singh

8 Howard College School of Law, University of KwaZulu Natal, Durban, South Africa

Katherine Littler

7 Health Ethics and Governance Unit, WHO, Geneva, GE, Switzerland

Chelsea Modlin

2 Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland, USA

Lee-Anne Pascoe

7 Health Ethics and Governance Unit, WHO, Geneva, GE, Switzerland